Literature DB >> 8018365

The general mammography screening program in Stockholm. Organisation and first-round results.

E K Lidbrink1, S A Törnberg, E M Azavedo, J O Frisell, M L Hjalmar, K S Leifland, T B Sahlstedt, L Skoog.   

Abstract

This presentation describes the organization and first-round results of the Stockholm mass mammography screening program, and discusses ways of checking the quality of an ongoing screening program. The Stockholm mammography screening program started in 1989 at five independent screening units, and comprises more than 150,000 women aged 50 to 69 years. The first round was completed in June 1991. Compliance during the studied period was 70.6%, and the recall rate was 3.0% of the attending women. Breast cancer was diagnosed in 676 women, of whom 90 (13.3%) had a cancer in situ. The cancer prevalence rate was thus 6.3 cancers per 1,000 screened women. Surgery was performed on 925 women, of whom 249 had benign lesions, giving a benign/malignant ratio of 0.37 to 1. Fifty-two per cent of the cancer patients were operated with breast conserving surgery. The median size of the invasive cancers was 12 mm; almost 80% were node-negative. Experience from the first two years of this mass mammography screening program shows that it meets the major quality requirements. One of the main future goals is to maintain the high quality of the program. Another important goal is a further increase in compliance.

Entities:  

Mesh:

Year:  1994        PMID: 8018365     DOI: 10.3109/02841869409098428

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Changes in Benign to Malignant Ratio of Surgically Treated Breast Diseases in a District Hospital.

Authors:  Gábor Cserni
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Breast Cancer Screening Program in Stockholm County, Sweden - Aspects of Organization and Quality Assurance.

Authors:  Helena Lind; Gunilla Svane; Levent Kemetli; Sven Törnberg
Journal:  Breast Care (Basel)       Date:  2010-10-19       Impact factor: 2.860

3.  Women's patterns of participation in mammography screening in Denmark.

Authors:  My von Euler-Chelpin; Anne Helene Olsen; Sisse Njor; Ilse Vejborg; Walter Schwartz; Elsebeth Lynge
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial.

Authors:  E Lidbrink; J Elfving; J Frisell; E Jonsson
Journal:  BMJ       Date:  1996-02-03

5.  Prognosis of screen-detected breast cancers: results of a population based study.

Authors:  Laura Cortesi; Vincenzo E Chiuri; Silvia Ruscelli; Valeria Bellelli; Rossella Negri; Ivan Rashid; Claudia Cirilli; Antonella Fracca; Ennio Gallo; Massimo Federico
Journal:  BMC Cancer       Date:  2006-01-23       Impact factor: 4.430

6.  Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.

Authors:  Wendy Yi-Ying Wu; Sven Törnberg; Klara Miriam Elfström; Xijia Liu; Lennarth Nyström; Håkan Jonsson
Journal:  Breast Cancer Res       Date:  2018-12-17       Impact factor: 6.466

Review 7.  Screening for breast cancer: Cost-effective solutions for low- & middle-income countries.

Authors:  Gauravi A Mishra; Sharmila A Pimple; Indraneel Mittra; Rajendra A Badwe
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

8.  Mammography-based screening program: preliminary results from a first 2-year round in a Brazilian region using mobile and fixed units.

Authors:  Raphael Luiz Haikel; Edmundo Carvalho Mauad; Thiago Buosi Silva; Jacó Saraiva de Castro Mattos; Luciano Fernandes Chala; Adhemar Longatto-Filho; Nestor de Barros
Journal:  BMC Womens Health       Date:  2012-10-02       Impact factor: 2.809

9.  The South Australian Breast X-Ray Service: results from a statewide mammographic screening programme.

Authors:  J I Robinson; C E Crane; J M King; D I Scarce; C E Hoffmann
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.